Amlexanox Reduced Neuronal Injury in Study
Researchers found that the drug protected hippocampal cells in a mouse model of global cerebral ischemia.
Updated on Sept. 26, 2026 in Stroke
A recent study found that daily administration of amlexanox successfully reduced neuronal degeneration in the hippocampus of mice. The treatment, which targets PDE4B, appeared to preserve cellular integrity following induced global cerebral ischemia.
Why it matters
Identifying pharmacological ways to modulate lysosomal and autophagic processes could provide new therapeutic pathways for mitigating brain damage after ischemic events. This research offers a potential strategy for protecting sensitive hippocampal tissue from long-term injury.
Researchers administered a daily dosage of 10 mg/kg of amlexanox to mice via intraperitoneal injection. The study compared these results against control groups to measure hippocampal neuronal integrity and protein expression.
The details
The treatment worked by inhibiting PDE4B expression while simultaneously increasing the levels of proteins linked to autophagic and lysosomal activity. By altering the expression of apoptosis-related proteins, the drug successfully minimized cellular death within the hippocampus.
Timeline
September 26, 2026: Findings from the research were published.
The Big Picture
This study aligns with the ongoing investigation into phosphodiesterase 4B inhibitors as a mechanism for neuroprotection. The findings suggest a potential expansion in the clinical application of these inhibitors beyond their existing therapeutic uses.
While this discovery remains in the preclinical phase, it provides a vital foundation for future research into treatments for stroke survivors. It does not currently change any daily health routines or medical standards for patients.
The takeaway
This study highlights the importance of targeting autophagic processes to prevent secondary brain injury after an ischemic event. Future research will be necessary to determine if these neurological benefits translate to human health outcomes.
Further reading
For more information on current developments, visit the Stroke section.
Source note: This article includes information reported by Nature.
